Stocks News

LAST PRICE
133.3400
TODAY'S CHANGE (%)
Trending Down-4.6000 (-3.3348%)

Bid / Lots
132.5000/ 1
Ask / Lots
134.7200/ 1
Open / Previous Close
137.1100 / 137.9400
Day Range
Low 133.1500
High 138.8100
52 Week Range
Low 78.6700
High 173.2500
Volume
775,023
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 27, 2024
- DJ Sarepta Therapeutics Is Maintained at Overweight by Piper Sandler, from 11:37AM ET on Wednesday Nov 27, 2024 by Dow Jones
  11:37AM ET on Wednesday Nov 27, 2024 by Dow Jones
  Companies Mentioned: SRPT
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/SRPT/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 27, 2024 11:37 ET (16:37 GMT)
- DJ Sarepta Therapeutics Is Maintained at Buy by Needham, from 5:49AM ET on Wednesday Nov 27, 2024 by Dow Jones
  5:49AM ET on Wednesday Nov 27, 2024 by Dow Jones
  Companies Mentioned: SRPT
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/SRPT/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 27, 2024 05:49 ET (10:49 GMT)
Nov 26, 2024
- Sector Update: Health Care Stocks Higher Late Afternoon, from 3:48PM ET on Tuesday Nov 26, 2024 by MT Newswires
  3:48PM ET on Tuesday Nov 26, 2024 by MT Newswires
  Companies Mentioned: AMGN, ARWR, SRPT, MDAI, PLSE
  03:48 PM EST, 11/26/2024 (MT Newswires) -- Health care stocks rose late Tuesday afternoon, with the NYSE Health Care Index adding 0.5% and the Health Care Select Sector SPDR Fund (XLV) up 0.3%. The iShares Biotechnology ETF (IBB) was marginally high...
- Sector Update: Health Care Stocks Advance Tuesday Afternoon, from 1:49PM ET on Tuesday Nov 26, 2024 by MT Newswires
  1:49PM ET on Tuesday Nov 26, 2024 by MT Newswires
  Companies Mentioned: LLY, NVO, AMGN, ARWR, SRPT
  01:49 PM EST, 11/26/2024 (MT Newswires) -- Health care stocks rose Tuesday afternoon, with the NYSE Health Care Index adding 0.4% and the Health Care Select Sector SPDR Fund (XLV) up 0.2%. The iShares Biotechnology ETF (IBB) shed 0.3%. In corporate ...
- Sector Update: Health Care, from 1:31PM ET on Tuesday Nov 26, 2024 by MT Newswires
  1:31PM ET on Tuesday Nov 26, 2024 by MT Newswires
  Companies Mentioned: ARWR, SRPT
  01:31 PM EST, 11/26/2024 (MT Newswires) -- Health care stocks rose Tuesday afternoon, with the NYSE Health Care Index rising 0.5% and the Health Care Select Sector SPDR Fund (XLV) up 0.1%. The iShares Biotechnology ETF (IBB) shed 0.4%. In corporate ...

Today
- The Schall Law Firm Invites Stockholder Participation In An Inquiry Into Medpace Holdings Inc's Possible Securities Law Violations, from 2 hours ago by Accesswire
  2 hours ago by Accesswire
  Companies Mentioned: MEDP
- The Schall Law Firm Invites Stockholder Participation In An Inquiry Into Medpace Holdings Inc's Possible Securities Law Violations, from 2 hours ago by Dow Jones
  2 hours ago by Dow Jones
  Companies Mentioned: MEDP
Nov 27, 2024
- Exelixis to Webcast Fireside Chats as Part of Investor Conferences in December, from 4:05PM ET on Wednesday Nov 27, 2024 by Dow Jones
  4:05PM ET on Wednesday Nov 27, 2024 by Dow Jones
  Companies Mentioned: EXEL
- Medpace Holdings, Inc. Is Being Investigated For Fraud And Investors With Losses Are Urged To Contact The Schall Law Firm, from 12:00PM ET on Wednesday Nov 27, 2024 by Accesswire
  12:00PM ET on Wednesday Nov 27, 2024 by Accesswire
  Companies Mentioned: MEDP
- Medpace Holdings, Inc. Is Being Investigated For Fraud And Investors With Losses Are Urged To Contact The Schall Law Firm, from 12:00PM ET on Wednesday Nov 27, 2024 by Dow Jones
  12:00PM ET on Wednesday Nov 27, 2024 by Dow Jones
  Companies Mentioned: MEDP
- BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE, from 7:00AM ET on Wednesday Nov 27, 2024 by PR Newswire
  7:00AM ET on Wednesday Nov 27, 2024 by PR Newswire
  Companies Mentioned: TECH
- BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE, from 7:00AM ET on Wednesday Nov 27, 2024 by Dow Jones
  7:00AM ET on Wednesday Nov 27, 2024 by Dow Jones
  Companies Mentioned: TECH
Nov 26, 2024
- DJ FDA to Review Exelixis' Application to Expand Use of Cancer Drug, from 5:58PM ET on Tuesday Nov 26, 2024 by Dow Jones
  5:58PM ET on Tuesday Nov 26, 2024 by Dow Jones
  Companies Mentioned: EXEL
- Exelixis Says US FDA Will Review Supplemental NDA for Prospective Treatment for Pancreatic Tumors in March, from 5:37PM ET on Tuesday Nov 26, 2024 by MT Newswires
  5:37PM ET on Tuesday Nov 26, 2024 by MT Newswires
  Companies Mentioned: EXEL
- Exelixis Provides Regulatory Update Related to Supplemental New Drug Application for Cabozantinib (CABOMETYX(R)) for the Treatment of Patients with Previously Treated Advanced Neuroendocrine Tumors, from 4:05PM ET on Tuesday Nov 26, 2024 by Dow Jones
  4:05PM ET on Tuesday Nov 26, 2024 by Dow Jones
  Companies Mentioned: EXEL

Sarepta Therapeutics Inc
NASDAQ:SRPTUnited States

Search Criteria

Nov 27, 2024

DJ Sarepta Therapeutics Is Maintained at Overweight by Piper Sandler, from 11:37AM ET on Wednesday Nov 27, 2024 by Dow Jones

DJ Sarepta Therapeutics Is Maintained at Buy by Needham, from 5:49AM ET on Wednesday Nov 27, 2024 by Dow Jones

Nov 26, 2024

Sector Update: Health Care Stocks Higher Late Afternoon, from 3:48PM ET on Tuesday Nov 26, 2024 by MT Newswires

Sector Update: Health Care Stocks Advance Tuesday Afternoon, from 1:49PM ET on Tuesday Nov 26, 2024 by MT Newswires

Sector Update: Health Care, from 1:31PM ET on Tuesday Nov 26, 2024 by MT Newswires

Peers Headlines

Today

The Schall Law Firm Invites Stockholder Participation In An Inquiry Into Medpace Holdings Inc's Possible Securities Law Violations, from 2 hours ago by Accesswire

The Schall Law Firm Invites Stockholder Participation In An Inquiry Into Medpace Holdings Inc's Possible Securities Law Violations, from 2 hours ago by Dow Jones

Nov 27, 2024

Exelixis to Webcast Fireside Chats as Part of Investor Conferences in December, from 4:05PM ET on Wednesday Nov 27, 2024 by Dow Jones

Medpace Holdings, Inc. Is Being Investigated For Fraud And Investors With Losses Are Urged To Contact The Schall Law Firm, from 12:00PM ET on Wednesday Nov 27, 2024 by Accesswire

Medpace Holdings, Inc. Is Being Investigated For Fraud And Investors With Losses Are Urged To Contact The Schall Law Firm, from 12:00PM ET on Wednesday Nov 27, 2024 by Dow Jones

BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE, from 7:00AM ET on Wednesday Nov 27, 2024 by PR Newswire

BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE, from 7:00AM ET on Wednesday Nov 27, 2024 by Dow Jones

Nov 26, 2024

DJ FDA to Review Exelixis' Application to Expand Use of Cancer Drug, from 5:58PM ET on Tuesday Nov 26, 2024 by Dow Jones

Exelixis Says US FDA Will Review Supplemental NDA for Prospective Treatment for Pancreatic Tumors in March, from 5:37PM ET on Tuesday Nov 26, 2024 by MT Newswires

Exelixis Provides Regulatory Update Related to Supplemental New Drug Application for Cabozantinib (CABOMETYX(R)) for the Treatment of Patients with Previously Treated Advanced Neuroendocrine Tumors, from 4:05PM ET on Tuesday Nov 26, 2024 by Dow Jones